Nivolumab

Nivolumab Reactions 1680, p259 - 2 Dec 2017 Ulcerative colitis: case report An 85-year-old woman developed ulcerative colitis during treatment with nivolumab [dosage and route not stated]. The woman, who had an 18 month history of lung adenocarcinoma, did not improved with chemotherapy including vinorelbine or docetaxel. Hence, she was started on nivolumab as a third-line therapy. She developed diarrhoea and haematochezia, three months after starting nivolumab. Fecal culture, serological tests and Clostridium difficile toxin assay did not reveal any significant findings. Subsequently, a colonoscopy showed loss of visible vascular pattern, purulent fluid throughout the colon and oedema. The endoscopic findings were indicative of ulcerative colitis. Eosin and haematoxylin staining of a biopsy specimen of colonic mucosa revealed goblet cell depletion, diffuse inflammatory cell infiltration and crypt abscess. Nivolumab-induced colitis was suspected based on the clinical course and the findings. The woman was started on methylprednisolone, and clinical symptoms resolved within a few days. A repeat endoscopy showed marked improvement after 3 weeks of therapy with methylprednisolone. Subsequently, methylprednisolone dose was gradually tapered with no recurrence of symptoms. Author comment: "Based on the clinical course and these findings, nivolumab-induced colitis was suspected." Abe K, et al. Inflammatory Bowel Disease in an Elderly Woman after Nivolumab Administration. American Journal of Gastroenterology 112: 1636, No. 11, Nov 2017. Available from: URL: http://doi.org/10.1038/ajg.2017.372 - Japan 803284792 0114-9954/17/1680-0001/$14.95 Adis © 2017 Springer International Publishing AG. All rights reserved Reactions 2 Dec 2017 No. 1680 http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Reactions Weekly Springer Journals

Nivolumab

Reactions Weekly , Volume 1680 (1) – Dec 2, 2017
Free
1 page
Loading next page...
1 Page
 
/lp/springer_journal/nivolumab-Z1zFrgOiUB
Publisher
Springer International Publishing
Copyright
Copyright © 2017 by Springer International Publishing AG, part of Springer Nature
Subject
Medicine & Public Health; Drug Safety and Pharmacovigilance; Pharmacology/Toxicology
ISSN
0114-9954
eISSN
1179-2051
D.O.I.
10.1007/s40278-017-39190-0
Publisher site
See Article on Publisher Site

Abstract

Reactions 1680, p259 - 2 Dec 2017 Ulcerative colitis: case report An 85-year-old woman developed ulcerative colitis during treatment with nivolumab [dosage and route not stated]. The woman, who had an 18 month history of lung adenocarcinoma, did not improved with chemotherapy including vinorelbine or docetaxel. Hence, she was started on nivolumab as a third-line therapy. She developed diarrhoea and haematochezia, three months after starting nivolumab. Fecal culture, serological tests and Clostridium difficile toxin assay did not reveal any significant findings. Subsequently, a colonoscopy showed loss of visible vascular pattern, purulent fluid throughout the colon and oedema. The endoscopic findings were indicative of ulcerative colitis. Eosin and haematoxylin staining of a biopsy specimen of colonic mucosa revealed goblet cell depletion, diffuse inflammatory cell infiltration and crypt abscess. Nivolumab-induced colitis was suspected based on the clinical course and the findings. The woman was started on methylprednisolone, and clinical symptoms resolved within a few days. A repeat endoscopy showed marked improvement after 3 weeks of therapy with methylprednisolone. Subsequently, methylprednisolone dose was gradually tapered with no recurrence of symptoms. Author comment: "Based on the clinical course and these findings, nivolumab-induced colitis was suspected." Abe K, et al. Inflammatory Bowel Disease in an Elderly Woman after Nivolumab Administration. American Journal of Gastroenterology 112: 1636, No. 11, Nov 2017. Available from: URL: http://doi.org/10.1038/ajg.2017.372 - Japan 803284792 0114-9954/17/1680-0001/$14.95 Adis © 2017 Springer International Publishing AG. All rights reserved Reactions 2 Dec 2017 No. 1680

Journal

Reactions WeeklySpringer Journals

Published: Dec 2, 2017

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve Freelancer

DeepDyve Pro

Price
FREE
$49/month

$360/year
Save searches from
Google Scholar,
PubMed
Create lists to
organize your research
Export lists, citations
Read DeepDyve articles
Abstract access only
Unlimited access to over
18 million full-text articles
Print
20 pages/month
PDF Discount
20% off